Vericel (VCEL) Revenue & Revenue Breakdown
Vericel Revenue Highlights
Latest Revenue (Y)
$276.26M
Latest Revenue (Q)
$67.50M
Main Segment (Y)
MACI Implants And Kits
Vericel Revenue by Period
Vericel Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $276.26M | 16.45% |
| 2024-12-31 | $237.22M | 20.10% |
| 2023-12-31 | $197.52M | 20.17% |
| 2022-12-31 | $164.37M | 5.24% |
| 2021-12-31 | $156.18M | 25.77% |
| 2020-12-31 | $124.18M | 5.37% |
| 2019-12-31 | $117.85M | 29.71% |
| 2018-12-31 | $90.86M | 42.13% |
| 2017-12-31 | $63.92M | 17.54% |
| 2016-12-31 | $54.38M | 6.28% |
| 2015-12-31 | $51.17M | 77.69% |
| 2014-12-31 | $28.80M | 151457.89% |
| 2013-12-31 | $19.00K | -9.52% |
| 2012-12-31 | $21.00K | 16.67% |
| 2011-12-31 | $18.00K | -79.78% |
| 2010-06-30 | $89.00K | -51.10% |
| 2009-06-30 | $182.00K | -65.13% |
| 2008-06-30 | $522.00K | -23.80% |
| 2007-06-30 | $685.00K | -20.63% |
| 2006-06-30 | $863.00K | -5.06% |
| 2005-06-30 | $909.00K | -30.18% |
| 2004-06-30 | $1.30M | 54.27% |
| 2003-06-30 | $844.00K | -3.76% |
| 2002-06-30 | $877.00K | -2.45% |
| 2001-06-30 | $899.00K | -21.83% |
| 2000-06-30 | $1.15M | 30.53% |
| 1999-06-30 | $881.00K | 253.82% |
| 1998-06-30 | $249.00K | -37.75% |
| 1997-06-30 | $400.00K | -75.00% |
| 1996-06-30 | $1.60M | - |
Vericel generated $276.26M in revenue during NA 2025, up 16.45% compared to the previous quarter, and up 222.47% compared to the same period a year ago.
Vericel Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $67.50M | 6.74% |
| 2025-06-30 | $63.24M | 20.23% |
| 2025-03-31 | $52.60M | -30.22% |
| 2024-12-31 | $75.38M | 30.17% |
| 2024-09-30 | $57.91M | 9.96% |
| 2024-06-30 | $52.66M | 2.69% |
| 2024-03-31 | $51.28M | -21.10% |
| 2023-12-31 | $65.00M | 42.59% |
| 2023-09-30 | $45.58M | -0.74% |
| 2023-06-30 | $45.92M | 11.96% |
| 2023-03-31 | $41.02M | -22.16% |
| 2022-12-31 | $52.69M | 36.69% |
| 2022-09-30 | $38.55M | 4.06% |
| 2022-06-30 | $37.05M | 2.69% |
| 2022-03-31 | $36.07M | -24.20% |
| 2021-12-31 | $47.59M | 37.92% |
| 2021-09-30 | $34.51M | -12.69% |
| 2021-06-30 | $39.52M | 14.32% |
| 2021-03-31 | $34.57M | -23.57% |
| 2020-12-31 | $45.23M | 40.21% |
| 2020-09-30 | $32.26M | 61.18% |
| 2020-06-30 | $20.01M | -24.98% |
| 2020-03-31 | $26.68M | -32.27% |
| 2019-12-31 | $39.39M | 29.15% |
| 2019-09-30 | $30.50M | 16.63% |
| 2019-06-30 | $26.15M | 19.90% |
| 2019-03-31 | $21.81M | -30.40% |
| 2018-12-31 | $31.34M | 39.37% |
| 2018-09-30 | $22.48M | 18.27% |
| 2018-06-30 | $19.01M | 5.46% |
| 2018-03-31 | $18.03M | -22.80% |
| 2017-12-31 | $23.35M | 63.74% |
| 2017-09-30 | $14.26M | -15.89% |
| 2017-06-30 | $16.95M | 81.10% |
| 2017-03-31 | $9.36M | -43.35% |
| 2016-12-31 | $16.52M | 51.18% |
| 2016-09-30 | $10.93M | -14.77% |
| 2016-06-30 | $12.82M | -9.11% |
| 2016-03-31 | $14.11M | -8.51% |
| 2015-12-31 | $15.42M | 36.35% |
| 2015-09-30 | $11.31M | -16.78% |
| 2015-06-30 | $13.59M | 25.27% |
| 2015-03-31 | $10.85M | -26.23% |
| 2014-12-31 | $14.71M | 52.27% |
| 2014-09-30 | $9.66M | 117.92% |
| 2014-06-30 | $4.43M | 100.00% |
| 2014-03-31 | - | -100.00% |
| 2013-12-31 | $8.00K | 100.00% |
| 2013-09-30 | - | -100.00% |
| 2013-06-30 | $3.00K | -62.50% |
| 2013-03-31 | $8.00K | -57.89% |
| 2012-12-31 | $19.00K | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | -100.00% |
| 2012-03-31 | $2.00K | 100.00% |
| 2011-12-31 | - | -100.00% |
| 2011-09-30 | $9.00K | 100.00% |
| 2011-06-30 | - | -100.00% |
| 2011-03-31 | $9.00K | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | -100.00% |
| 2009-12-31 | $16.00K | -78.08% |
| 2009-09-30 | $73.00K | 5.80% |
| 2009-06-30 | $69.00K | 18.97% |
| 2009-03-31 | $58.00K | 107.14% |
| 2008-12-31 | $28.00K | 3.70% |
| 2008-09-30 | $27.00K | -81.88% |
| 2008-06-30 | $149.00K | -26.24% |
| 2008-03-31 | $202.00K | - |
Vericel generated $67.50M in revenue during Q3 2025, up 6.74% compared to the previous quarter, and up 128.18% compared to the same period a year ago.
Vericel Revenue Breakdown
Vericel Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| MACI Implants And Kits | $239.51M | $197.31M | $164.80M | $131.97M | $111.55M |
Latest
Vericel's latest annual revenue breakdown by segment (product or service), as of Dec 25: MACI Implants And Kits (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Sep 20 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MACI Implants And Kits | $84.09M | $55.66M | $53.46M | $46.30M | $68.34M | $44.66M | $44.13M | $40.18M | $94.27M | $36.34M | $34.19M | - | - | - | - | - | - | - | - | - |
| MACI Implants And Kits Member | - | - | - | - | - | - | - | - | - | - | - | $31.01M | $28.61M | $26.00M | - | - | - | - | - | - |
| MACI Implants and Kits, and Epicel | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $33.72M | $38.68M | $33.63M | $31.02M | - | - |
| Product | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $30.50M | $26.15M |
Latest
Vericel's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: MACI Implants And Kits (100.00%).
Vericel Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HRMY | Harmony Biosciences | $868.45M | $239.46M |
| MNKD | MannKind | $348.97M | $82.13M |
| AUPH | Aurinia Pharmaceuticals | $283.06M | $73.47M |
| VCEL | Vericel | $276.26M | $67.50M |
| VRDN | Viridian Therapeutics | $70.85M | $70.57M |
| NUVB | Nuvation Bio | $62.90M | $13.12M |
| OCUL | Ocular Therapeutix | $51.82M | $14.54M |
| QURE | uniQure | $16.10M | $3.70M |
| MESO | Mesoblast | $7.50M | $1.69M |
| GPCR | Structure Therapeutics | - | - |
| EWTX | Edgewise Therapeutics | - | - |